CAS 1469988-75-7

QL47

Description:

As of my last update in October 2023, there is limited publicly available information regarding the chemical substance QL47, identified by the CAS number 1469988-75-7. This compound is not widely recognized in mainstream chemical databases or literature, suggesting it may be a novel or specialized compound, possibly under research or development in specific fields such as pharmaceuticals or materials science. Typically, substances like this may exhibit unique properties such as specific solubility, reactivity, or biological activity, depending on their molecular structure and functional groups. For accurate and detailed characteristics, including its physical and chemical properties, safety data, and potential applications, consulting specialized scientific literature or proprietary databases would be necessary. Additionally, information from the manufacturer or research institution involved in its study may provide insights into its synthesis, uses, and safety considerations.

QL47

CAS: 1469988-75-7

QL47

Purity: ≥98%

Molecular weight: 447.49g/mol

Ref: 54-BUP22181

QL47

CAS: 1469988-75-7

QL47 acts as an inhibitor of viral translation and a BTK inhibitor with antiviral activity against dengue virus and can be used in the study of lymphoma.

Formula: C₂₇H₂₁N₅O₂

Purity: 98.11%

Color and Shape: Solid

Molecular weight: 447.49

Ref: TM-T16702

QL47

CAS: 1469988-75-7

QL47 is a molecule that inhibits phosphorylation of protein and translation. It also has anti-inflammatory properties and can be used to treat autoimmune diseases and inflammatory diseases. QL47 binds to the ferroelectric domain in the cell membrane, which is involved in cellular signaling. This binding prevents the formation of a phosphate-protein complex, which inhibits phosphorylation. The inhibition mechanism is due to the hydroxyl group on QL47, which interacts with the hydroxyl group on tyrosine residues in proteins and blocks their access to phosphate groups. QL47 can be detected using mass spectrometry methods and has been shown to have pharmacokinetic properties that are dependent on dose, blood flow rate, and tissue perfusion.

Formula: C₂₇H₂₁N₅O₂

Purity: Min. 95%

Molecular weight: 447.49 g/mol

Ref: 3D-UIC98875